{
  "meta": {
    "data_length": 1,
    "message": "Therapy name Brentuximab vedotin retrieved successfully",
    "request_url": "http://api.moalmanac.org/therapies?therapy_name=Brentuximab+vedotin",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.003344,
    "timestamp_received": "2026-04-08T23:48:58.165978+00:00Z",
    "timestamp_returned": "2026-04-08T23:48:58.169322+00:00Z",
    "trace_id": "0beb6fee-70f5-4e01-a542-69843426d6bb"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://dev.moalmanac.org",
    "last_updated": "2026-03-05"
  },
  "data": [
    {
      "id": 0,
      "conceptType": "Drug",
      "name": "Brentuximab vedotin",
      "primaryCoding": {
        "id": "ncit:C66944",
        "code": "C66944",
        "name": "Brentuximab Vedotin",
        "system": "https://evsexplore.semantics.cancer.gov",
        "systemVersion": "25.01d",
        "iris": [
          "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C66944"
        ]
      },
      "mappings": [],
      "extensions": [
        {
          "name": "therapy_strategy",
          "value": [
            "target CD30 antigens"
          ],
          "description": "Associated therapeutic strategy or mechanism of action of the therapy."
        },
        {
          "name": "therapy_type",
          "value": "Targeted therapy",
          "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
        }
      ]
    }
  ]
}